A New Development by Gerresheimer - 2.25 ml Needle Syringe


Paris, - Gerresheimer presents a prefillable 2.25 ml needle syringe. The needle syringe is available in traditional tub and nest packaging.

This new product extends the comprehensive Gerresheimer range of sterile and non-sterile syringe systems which are supplied on a ready-to-fill basis to the pharma and biotech industries.

Numerous pharmaceutical manufacturers already changed over from purchasing prefillable syringes as bulk products to purchasing them as ready-to-fill products, i.e. washed, siliconized and sterilized with the tip caps or needle shield on. Gerresheimer markets these products under the RTF® (Ready-to-Fill) brand name.

The tub and nest packaging is the established norm for ready-to-fill syringes in the pharma industry. It permits processing of syringes from different suppliers on the filling lines without major retrofitting requirements.

Gerresheimer's 2.25 ml needle syringe is available in the conventional tub and nest configuration, which means the pharma manufacturers don't have to perfom any complex production line modifications.

The new product is available with a round or cut finger flange and it is supplied with a ½" needle and rigid needle shield. Each tub and nest packaging contains 100 syringes.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.

Our Group realizes revenues of around one billion euros and has around 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

All Topics